Sergio Raposeiras Roubin
Overview
Explore the profile of Sergio Raposeiras Roubin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elena G, Losada E, Sergio R, Raposeiras Roubin S
Kardiol Pol
. 2025 Jan;
82(11):1057-1058.
PMID: 39743948
No abstract available.
2.
De Filippo O, Wanha W, Sanavia T, Januszek R, Giacobbe F, Campo G, et al.
EuroIntervention
. 2024 Nov;
20(21):e1340-e1354.
PMID: 39492702
Background: Limited data exist on ultrathin-strut drug-eluting stent (ultrathin DES) performance in DES in-stent restenosis (ISR). Aims: We aimed to assess the efficacy and safety of ultrathin DES compared to...
3.
Raposeiras Roubin S, Lopez Canoa N
Med Clin (Barc)
. 2024 Jul;
163(11):568-569.
PMID: 39034182
No abstract available.
4.
Schweiger V, Di Vece D, Cammann V, Koleva I, Wurdinger M, Gilhofer T, et al.
Eur Heart J
. 2024 May;
45(25):2254-2258.
PMID: 38717630
No abstract available.
5.
Parada Barcia J, Raposeiras Roubin S, Fernandez D, Garcia A, Otero C, Gonzalez Bermudez I, et al.
Clin Cardiol
. 2024 Apr;
47(5):e24257.
PMID: 38664980
Background: Rate control is the most commonly employed first-line management strategy for atrial fibrillation (AF) in patients with chronic kidney disease (CKD). Principal agents used to control heart rate (HR)...
6.
Abu-Assi E, Lizancos Castro A, Cespon-Fernandez M, Gonzalez-Bermudez I, Raposeiras Roubin S
Int J Cardiol
. 2024 Apr;
407:132018.
PMID: 38579940
Background: Recently, the direct oral anticoagulant (DOAC) score was developed and better predicted major bleeding in DOAC-treated patients with atrial fibrillation (AF) than HASBLED did. Little is known on the...
7.
Bruno F, De Filippo O, Sardone A, Capranzano P, Conrotto F, Sheiban I, et al.
Int J Cardiol
. 2024 Feb;
401:131861.
PMID: 38365014
Introduction: The potential benefit on long term outcomes of Percutaneous Coronary Intervention (PCI) on Unprotected Left Main (ULM) driven by IntraVascular UltraSound (IVUS) remains to be defined. Methods: IMPACTUS LM-PCI...
8.
DAscenzo F, Fabris E, Gregorio C, Mittone G, De Filippo O, Wanha W, et al.
Am J Cardiol
. 2023 Dec;
224:55.
PMID: 38114059
No abstract available.
9.
Elia E, Bruno F, Crimi G, Wanha W, Leonardi S, Mauro M, et al.
Int J Cardiol
. 2023 Dec;
397:131622.
PMID: 38061607
Background: Impact of gender on heart remodeling after acute coronary syndrome (ACS) and consequently on development of heart failure (HF) remains to be elucidated. Methods: CORALYS is a multicenter, retrospective,...
10.
Ronco D, Ariza-Sole A, Kowalewski M, Matteucci M, Di Mauro M, Lopez-de-Sa E, et al.
Eur Heart J Open
. 2023 Oct;
3(5):oead091.
PMID: 37840585
Aims: Many historical and recent reports showed that post-infarction ventricular septal rupture (VSR) represents a life-threatening condition and the strategy to optimally manage it remains undefined. Therefore, disparate treatment policies...